Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

Journal: Science

Published: 2021-03-12

DOI: 10.1126/science.abg6105

Affiliations: 3

Authors: 12

Go to article
Institutions Share
BioNTech AG, Germany 0.54
Pfizer Inc., United States of America (USA) 0.42
Translational Oncology (TRON), Germany 0.04

Return